zm 336372 has been researched along with Cancer of Pancreas in 1 studies
N-(5-(3-dimethylaminobenzamido)-2-methylphenyl)-4-hydroxybenzamide: an inhibitor of c-Raf; activates Raf-1; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deming, D | 1 |
| Geiger, P | 1 |
| Chen, H | 1 |
| Kunnimalaiyaan, M | 1 |
| Holen, K | 1 |
1 other study available for zm 336372 and Cancer of Pancreas
| Article | Year |
|---|---|
ZM336372 induces apoptosis associated with phosphorylation of GSK-3beta in pancreatic adenocarcinoma cell lines.
Topics: Adenocarcinoma; Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Drug Evaluation, Precli | 2010 |